Myocarditis Differential Diagnoses
- Author: Wai Hong Wilson Tang, MD; Chief Editor: Henry H Ooi, MBBCh more...
Diagnostic Considerations
A new entity of transient cardiac dysfunction has evolved, known as takotsubo cardiomyopathy or transient apical ballooning syndrome. It is characterized by severe hypokinesis of the anteroapical and inferoapical regions of the heart for unclear reason, and often with complete resolution. Many cases have been associated with a psychological or stressful event. Some have suggested a myocarditis nature of the condition, but the precise understanding of this syndrome remains unclear.
Conditions to consider in the differential diagnosis of myocarditis include the following:
- Coronary artery vasospasm
- Isolated coronary artery anomalies
- Myocardial infarction
- Myocardial ischemia
- Cardiogenic pulmonary edema
- High-altitude pulmonary edema
- Neurogenic pulmonary edema
- Interstitial (nonidiopathic) pulmonary fibrosis
- Sudden cardiac death
- Unstable angina
- Ventricular tachycardia
Differential Diagnoses
- Cardiac Tamponade
- Cardiogenic Shock
- Cardiomyopathy, Alcoholic
- Cardiomyopathy, Cocaine
- Cardiomyopathy, Dilated
- Cardiomyopathy, Hypertrophic
- Cardiomyopathy, Peripartum
- Cardiomyopathy, Restrictive
- Chagas Disease (American Trypanosomiasis)
- Coronary Artery Atherosclerosis
Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. Jan 1987;1(1):3-14. [Medline].
Feldman AM, McNamara D. Myocarditis. N Engl J Med. Nov 9 2000;343(19):1388-98. [Medline].
Venteo L, Bourlet T, Renois F, et al. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur Heart J. Nov 19 2009;[Medline].
Bowles NE, Towbin JA. Molecular aspects of myocarditis. Curr Opin Cardiol. May 1998;13(3):179-84. [Medline].
Badorff C, Knowlton KU. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside. Med Microbiol Immunol (Berl). May 2004;193(2-3):121-6. [Medline].
Klugman D, Berger JT, Sable CA, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. Nov 21 2009;[Medline].
Kuhl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation. Feb 22 2005;111(7):887-93. [Medline].
Karjalainen J, Heikkila J. Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J. Aug 1999;20(15):1120-5. [Medline].
Durani Y, Egan M, Baffa J, et al. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. Oct 2009;27(8):942-7. [Medline].
Wakafuji S, Okada R. Twenty year autopsy statistics of myocarditis incidence in Japan. Jpn Circ J. Dec 1986;50(12):1288-93. [Medline].
Pulerwitz TC, Cappola TP, Felker GM, et al. Mortality in primary and secondary myocarditis. Am Heart J. Apr 2004;147(4):746-50. [Medline].
McCarthy RE 3rd, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. Mar 9 2000;342(10):690-5. [Medline].
Lauer B, Schannwell M, Kuhl U, et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol. Jan 2000;35(1):11-8. [Medline].
Fuse K, Kodama M, Okura Y, Ito M, Hirono S, Kato K, et al. Predictors of disease course in patients with acute myocarditis. Circulation. Dec 5 2000;102(23):2829-35. [Medline].
D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. May 2001;85(5):499-504. [Medline].
Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. Apr 4 1985;312(14):885-90. [Medline].
Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. Mar 2 1999;99(8):1091-100. [Medline].
Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. Aug 3 1995;333(5):269-75. [Medline].
Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. Jun 26 1997;336(26):1860-6. [Medline].
Rosenstein ED, Zucker MJ, Kramer N. Giant cell myocarditis: most fatal of autoimmune diseases. Semin Arthritis Rheum. Aug 2000;30(1):1-16. [Medline].
Al-Mallah M, Kwong RY. Clinical application of cardiac CMR. Rev Cardiovasc Med. Summer 2009;10(3):134-41. [Medline].
Monney PA, Sekhri N, Burchell T, et al. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart. Aug 2011;97(16):1312-8. [Medline].
Karatolios K, Pankuweit S, Maisch B. Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy. Curr Treat Options Cardiovasc Med. December 2007;9:473-81. [Medline].
Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. Nov 2007;116:2216-33. [Medline]. [Full Text].
Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. Jun 2010;16(6):e1-194. [Medline].
Hufnagel G, Pankuweit S, Richter A, et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz. May 2000;25(3):279-85. [Medline].
Wang JF, Meissner A, Malek S, Chen Y, Ke Q, Zhang J, et al. Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. Am J Physiol Heart Circ Physiol. Oct 2005;289(4):H1577-83. [Medline].
Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. Oct 19 1989;321(16):1061-8. [Medline].
McNamara DM, Starling RC, Dec GW. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation. 1999;100 (Suppl):I-21.
Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. Feb 18 2003;107(6):857-63. [Medline].
Rajagopal SK, Almond CS, Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med. Sep 28 2009;[Medline].

